Steady T
I do check in several times during the day and thanks for your answer, I guess Chris Missling operates like a Jack-In-The Box keeping everything under wraps until he eventually releases information to shareholders, both good news and bad.
My expectations after Excellence Trial have been like a camp fire being smothered with a cold rag & I believe as some others here do that his efforts are trying to use information from 2-73 and 3-71 together to enhance favorable review of data.
The facts are: a pill once a day, safety, with some noticeable favorable effect on well being....with no brain bleeding. I certainly hope that is what Dr. Jin has suggested to this company.
News 
Market Data 
Discover 
